Delivery Order SPE2DB22D2006-SPE2DB23FV9QW
Award Date 5/8/23
Potential Completion Date 5/9/23
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $64,160.87 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets in 100-count bottles, with a performance period through April 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.40 firm-fixed-price contract is for the delivery of Plaquenil 200 mg tablets. The contract has a completion date of March 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,358.25 firm-fixed-price delivery order is for 4,560,912,861 tablets of Plaquenil (hydroxychloroquine sulfate 200 mg), a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract has a completion date of May 12, 2023 and was awarded on May 11, 2023. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.16 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP4U7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $37,074.61 firm fixed-price delivery order is for the supply of 4,561,920,233 units of the prescription drug Plaquenil 200 mg tablets. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,726.73, is for the delivery of Plaquenil 200 mg tablets, a medication used to treat certain medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,182.82 fixed-price contract is for the delivery of Plaquenil (hydroxychloroquine) 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of Plaquenil 200mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type. The total ceiling value of the contract is $12,209.57, with an ultimate completion date of August 2, 2024. This DO is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...